{"id":815326,"date":"2025-02-20T05:52:36","date_gmt":"2025-02-20T10:52:36","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/"},"modified":"2025-02-20T05:52:36","modified_gmt":"2025-02-20T10:52:36","slug":"contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/","title":{"rendered":"Contact The Gross Law Firm by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK)"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n NEW YORK<\/span>
\n <\/span>, Feb. 20, 2025<\/span><\/span> \/PRNewswire\/ — The Gross Law Firm issues the following notice to shareholders of\u00a0GSK plc (NYSE: GSK).<\/b><\/p>\n

\n

\n
\n \"The
\n <\/a>\n <\/p>\n<\/p><\/div>\n

Shareholders who purchased shares of GSK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n

CONTACT US HERE:<\/p>\n

\n https:\/\/securitiesclasslaw.com\/securities\/gsk-loss-submission-form\/?id=130540&from=4<\/a>\n <\/p>\n

\n CLASS PERIOD: <\/b>
\n February 5, 2020<\/span> to August 14, 2022<\/span><\/p>\n

\n ALLEGATIONS: <\/b>According to the filed complaint, defendants represented to investors that GSK removed Zantac from the market “[b]ased on information available at the time and correspondence with regulators.” GSK also stated that it was “continuing with investigations into the potential source of NDMA.” Defendants also assured investors that “GSK, the FDA, and the EMA [European Medicines Agency] have all independently concluded that there is no evidence of a causal association between ranitidine therapy and the development of cancer in patients,” findings that were “consistent with other ranitidine data published prior to 2019.” Finally, defendants claimed that they could not “quantify or reliably estimate the liability.” These representations were materially false or misleading. In truth, GSK was fully aware of the source of NDMA and had been for nearly 40 years before withdrawing Zantac from the market.<\/p>\n

\n DEADLINE: April 7, 2025<\/span><\/b> Shareholders should not delay in registering for this class action. Register your information here: https:\/\/securitiesclasslaw.com\/securities\/gsk-loss-submission-form\/?id=130540&from=4<\/a><\/p>\n

\n NEXT STEPS FOR SHAREHOLDERS: <\/b>Once you register as a shareholder who purchased shares of GSK during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is April 7, 2025<\/span>. There is no cost or obligation to you to participate in this case.<\/p>\n

\n WHY GROSS LAW FIRM? <\/b>The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud<\/span>, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and\/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n

\n CONTACT:<\/b>
\n
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY<\/span>, 10018
Email: dg@securitiesclasslaw.com<\/a>
Phone: (646) 453-8903<\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk-302380838.html<\/a><\/p>\n

SOURCE The Gross Law Firm<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire NEW YORK , Feb. 20, 2025 \/PRNewswire\/ — The Gross Law Firm issues the following notice to shareholders of\u00a0GSK plc (NYSE: GSK). Shareholders who purchased shares of GSK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/gsk-loss-submission-form\/?id=130540&from=4 CLASS PERIOD: February 5, 2020 to August 14, 2022 ALLEGATIONS: According to the filed complaint, defendants represented to investors that GSK removed Zantac from the market “[b]ased on information available at the time and correspondence with regulators.” GSK also stated that it was “continuing with investigations into the potential source of NDMA.” Defendants also assured investors that “GSK, … <\/p>\n

Continue reading “Contact The Gross Law Firm by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK)”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-815326","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nContact The Gross Law Firm by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Contact The Gross Law Firm by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , Feb. 20, 2025 \/PRNewswire\/ — The Gross Law Firm issues the following notice to shareholders of\u00a0GSK plc (NYSE: GSK). Shareholders who purchased shares of GSK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/gsk-loss-submission-form\/?id=130540&from=4 CLASS PERIOD: February 5, 2020 to August 14, 2022 ALLEGATIONS: According to the filed complaint, defendants represented to investors that GSK removed Zantac from the market “[b]ased on information available at the time and correspondence with regulators.” GSK also stated that it was “continuing with investigations into the potential source of NDMA.” Defendants also assured investors that “GSK, … Continue reading "Contact The Gross Law Firm by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK)"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-20T10:52:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Contact The Gross Law Firm by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK)\",\"datePublished\":\"2025-02-20T10:52:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\\\/\"},\"wordCount\":455,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\\\/\",\"name\":\"Contact The Gross Law Firm by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"datePublished\":\"2025-02-20T10:52:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Contact The Gross Law Firm by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Contact The Gross Law Firm by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/","og_locale":"en_US","og_type":"article","og_title":"Contact The Gross Law Firm by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK) - Market Newsdesk","og_description":"PR Newswire NEW YORK , Feb. 20, 2025 \/PRNewswire\/ — The Gross Law Firm issues the following notice to shareholders of\u00a0GSK plc (NYSE: GSK). Shareholders who purchased shares of GSK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/gsk-loss-submission-form\/?id=130540&from=4 CLASS PERIOD: February 5, 2020 to August 14, 2022 ALLEGATIONS: According to the filed complaint, defendants represented to investors that GSK removed Zantac from the market “[b]ased on information available at the time and correspondence with regulators.” GSK also stated that it was “continuing with investigations into the potential source of NDMA.” Defendants also assured investors that “GSK, … Continue reading \"Contact The Gross Law Firm by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-20T10:52:36+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Contact The Gross Law Firm by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK)","datePublished":"2025-02-20T10:52:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/"},"wordCount":455,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/","name":"Contact The Gross Law Firm by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","datePublished":"2025-02-20T10:52:36+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/contact-the-gross-law-firm-by-april-7-2025-deadline-to-join-class-action-against-gsk-plcgsk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Contact The Gross Law Firm by April 7, 2025 Deadline to Join Class Action Against GSK plc(GSK)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815326","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=815326"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815326\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=815326"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=815326"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=815326"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}